Oral Solids Continue to Dominate the Excipients Market

Oral Solids Continue to Dominate the Excipients Market, While the Parenteral Route Accelerates Growth

By definition, excipients are inactive substances that serve as a medium or vehicle for pharmaceutical active drug substances. Over the years, excipients have been increasingly developed to provide important functionalities to pharmaceutical formulations. The global pharmaceutical market is worth more than USD 1.1 trillion as of 2017 and expected to grow more than 4% annually over the next five years. The global market of specialty excipients in the overall pharmaceutical industry is estimated at about USD 6.8 billion in 2017.Continue reading

Specialty Excipients for Oral Solid-Dosage-Form Pharmaceuticals

The specialty excipients market for oral-solid-dosage-form pharmaceuticals will grow close to 6% during 2016-2021

Pharmaceuticals is one of the largest and most essential industries worldwide. The global pharmaceutical market is worth over USD 1.1 trillion as of 2016 and is expected to grow in the range of 4%-7% annually over the next five years. Among the several routes of drug administration prevalent in the pharmaceutical industry, oral route is the most widely used, accounting for around 55% of the global pharmaceuticals market value. Furthermore, within orals, solid formulations are the most preferred dosages for their ease of administration, dosage accuracy, stability, and cost-effectiveness. OSDFs is a key growth segment for the global healthcare industry, especially with the growing emphasis on expanding affordable healthcare. Continue reading

Specialty Excipients for Oral Solid-Dosage-Form

The Expansion of Healthcare Will Drive the Demand for OSDF Excipients

The expansion of affordable healthcare and robust growth in generics due to increasing patent expirations of branded drugs are boosting consumption of specialty oral solid-dosage-form (OSDF) excipients globally. According to Kline’s recently published Specialty Excipients for OSDFs Database, the markets in China, CIS, Europe, India, Japan, and the United States are estimated at USD 3.5 billion and expected to grow at a compound annual growth rate (CAGR) of close to 6% during 2016-2021. While the growth is foreseen at all the industry levels, the key factors driving the growth in mature and “pharmerging” markets vary widely. In this blog, we look deeper into the most important market issues and trends affecting the industry and how suppliers can use them in their favor.Continue reading

The Markets for Excipients in the Middle East, Africa, and Southeast Asia

The Markets for Excipients in the Middle East, Africa, and Southeast Asia Render Untapped Potential with Above-average Growth, According to Kline

Southeast Asia is the fastest growing pharmaceutical market in the world, witnessing strong double-digit growth since 2011, with growth of excipients consumption in the region also strong and estimated to increase at a compound annual growth rate of 13.4% through 2020, finds recently published Specialty Excipients for Oral Solid-Dosage-Form Pharmaceuticals: Emerging Markets Analysis and Opportunities by global market research and management consulting firm Kline. Another excipients market analyzed in the report with solid pockets of opportunity is the Middle East and Africa region, forecast to progress at nearly 8% through 2020.Continue reading